Clinical Trial: Amphotericin B Treatment in Visceral Leishmaniasis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis

Brief Summary: This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.

Detailed Summary: This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.
Sponsor: Banaras Hindu University

Current Primary Outcome: Final cure rate at six months after the end of treatment

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Banaras Hindu University

Dates:
Date Received: April 3, 2006
Date Started: January 2003
Date Completion:
Last Updated: September 11, 2008
Last Verified: September 2008